🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this trial is to test whether treatment with tralokinumab (a...
Status
Recruiting
Location
Leo Pharma Investigational site
Start Date
2024-06-10
Trial ID
NCT06311682
Treatments Being Tested
Atopic dermatitis, also called eczema, is characterized by redness, papulat...
Status
Completed
Location
Pediatric Care Medical Group, Inc.
Start Date
2005-05
Trial ID
NCT00121381
This is a Phase 1b, randomized, placebo/vehicle-controlled, double-blinded,...
Status
Recruiting
Location
University of California, San Diego: Dermatology Clinical Trials Unit
Start Date
2025-05-22
Trial ID
NCT06504160
Craniosacral exploration and therapy is one of the innovative palpation and...
Status
Completed
Location
Gema León Physiotherapy and Rehabilitation Clinic
Start Date
2021-12-18
Trial ID
NCT05340049
Treatments Being Tested
To investigate the safety and tolerability of repeated subcutaneous (s.c.) ...
Status
Terminated
Location
First OC Dermatology
Start Date
2019-03-25
Trial ID
NCT03864627
Tobacco control is a Public Health priority. Tobacco is directly responsibl...
Status
Completed
Location
Chu Dijon Bourgogne
Start Date
2020-06-29
Trial ID
NCT04591743
Treatments Being Tested
Pediatric atopic dermatitis (AD), also known as childhood eczema, is a skin...
Status
Active Not Recruiting
Location
Central Clinic - Nagoya /ID# 269205
Start Date
2024-12-22
Trial ID
NCT06701331
Treatments Being Tested
Major depressive disorder (MDD) is a common, recurrent, and frequent chroni...
Status
Unknown
Location
Ludwig-Maximilian University
Start Date
2021-06-22
Trial ID
NCT04953208
Treatments Being Tested
This phase 2b study is designed to evaluate the safety and efficacy of teze...
Status
Terminated
Location
First OC Dermatology
Start Date
2019-03-15
Trial ID
NCT03809663
Treatments Being Tested
This extension study (CZPL389A2203E1) was designed as a 2-year (100 weeks) ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-04-04
Trial ID
NCT03948334
Treatments Being Tested